The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Immunotherapy is a biological therapy and type of targeted treatment that boosts the patient’s natural defence, the immune system, and enables it to find and destroy cancer cells found in the body. At Rutherford Cancer Centres, we use several different types of immunotherapy in the treatment of cancer, in order to prevent cells growing and replicating or spreading around the body.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr Esme Hill graduated from Birmingham University, also completing an Intercalated BSc in the History of Medicine at University College London before training as physician in the West Midlands. Dr Hill decided to specialise in Oncology and completed her training at the Royal Free Hospital and then as a Specialist Registrar in Clinical Oncology on the Oxford Clinical Oncology training scheme.
Dr Hill has extensive experience in the management of acutely unwell cancer patients, with a weekly session dedicated to “Acute Oncology”. Dr Hill is the malignant spinal cord compression clinical lead at the Royal Berkshire Hospital in Reading as well as an Educational Supervisor to Core Medical trainees.
She's a core member of the Upper Gastrointestinal Cancer Multi-Disciplinary Teams and Cancer of Unknown Primary Multi-Disciplinary Teams at both the Royal Berkshire Hospital, Reading and Wexham Park Hospital, Slough. She attends the Oxford Oesophago-gastric and Hepato-biliary Multi-Disciplinary Team meetings on a weekly basis via video-conference and has a strong working relationship with the Oxford teams.
Upper Gastrointestinal Cancer Multi-Disciplinary Team (Royal Berkshire Hospital, Reading and Wexham Park Hospital)
Cancer of Unknown Primary Multi-Disciplinary Team (Royal Berkshire Hospital, Reading and Wexham Park Hospital)
Dr Esme Hill does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr Esme Hill does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr Esme Hill does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or